O31: Risk allele evidence curation, classification, and reporting: Recommendations from the ClinGen Low Penetrance/Risk Allele Working Group*

• Matthew Lebo,
• Marcie Steeves,
• Katherine Benson,
• Laura Conlin,
• Mythily Ganapathi,
• Vaidehi Jobanputra,
• Minjie Luo,
• Deqiong Ma,
• Kelly McGoldrick,
• Blake Palculict,
• Heidi Rehm,
• Panagiotis Sergouniotis,
• Samantha Schilit,
• Pinar Bayrak-Toydemir,
• Tatiana Tvrdik,
• Nicholas Watkins,
• Lauren Zec,
• Wenying Zhang Zhang,
• Ryan Schmidt

Affiliations

Matthew Lebo

Mass General Brigham, Brigham and Women's Hospital, Broad Institute of MIT and Harvard

Marcie Steeves

Color Health, Inc.

Katherine Benson

Royal College of Surgeons in Ireland

Laura Conlin

Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania

Mythily Ganapathi

Columbia University Irving Medical Center

Vaidehi Jobanputra

New York Genome Center; Columbia University Irving Medical Center

Minjie Luo

Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania

Deqiong Ma

DNA Diagnostic Lab, School of Medicine, Yale University

Kelly McGoldrick

Ambry Genetics

Blake Palculict

GeneDx/Sema4

Heidi Rehm

Massachusetts General Hospital, Broad Institute of MIT and Harvard

Panagiotis Sergouniotis

University of Manchester, UK

Samantha Schilit

Mass General Brigham

Pinar Bayrak-Toydemir

University of Utah, ARUP Laboratories

Tatiana Tvrdik

Emory University School of Medicine

Nicholas Watkins

Sinai Health System

Lauren Zec

Natera

Wenying Zhang Zhang

Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine

Ryan Schmidt

Children's Hospital Los Angeles, Keck School of Medicine of USC